Ebos Group (FRA:EJG) Retained Earnings : €319 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Ebos Group Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Ebos Group's retained earnings for the quarter that ended in Dec. 2024 was €319 Mil.

Ebos Group's quarterly retained earnings increased from Dec. 2023 (€303 Mil) to Jun. 2024 (€327 Mil) but then declined from Jun. 2024 (€327 Mil) to Dec. 2024 (€319 Mil).

Ebos Group's annual retained earnings increased from Jun. 2022 (€321 Mil) to Jun. 2023 (€345 Mil) but then declined from Jun. 2023 (€345 Mil) to Jun. 2024 (€327 Mil).

Ebos Group Retained Earnings Historical Data

The historical data trend for Ebos Group's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ebos Group Retained Earnings Chart

Ebos Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Retained Earnings

Get a 7-Day Free Trial

227.97

274.74

320.98

344.74

327.42

Ebos Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Retained Earnings	Get a 7-Day Free Trial															341.03	344.74	302.84	327.42	319.15

Ebos Group Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Ebos Group (FRA:EJG) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Ebos Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Ebos Group Ltd (FRA:EJG) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

EBO:New Zealand EBO:Australia

Address

737 Bourke Street, Level 7, Docklands, Melbourne, VIC, AUS, 3008

Website

https://www.ebosgroup.com

Ebos is the largest pharmaceutical wholesaler and distributor across Australia and New Zealand. It services community pharmacies and hospitals, which contribute around 60% and 30% of revenue, respectively. Drug pricing and wholesale margins for PBS medicine are governed by the Australian government's Pharmaceutical Benefits Scheme, or PBS. Wholesale gross margins are capped at 7% for community pharmacy and 10% for hospitals, and ongoing price reform typically results in low-single-digit revenue growth. Aside from pharma distribution, Ebos operates an animal health product wholesale, manufacturing and retail business, as well as undertaking third party logistics services. These segments are smaller contributors to group revenue but due to the unregulated nature are higher-margin operations.

Ebos Group Headlines

No Headlines